Clinical Trials Directory

Trials / Completed

CompletedNCT02937623

To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)

A Proof-of-principle Clinical Study Investigating the Efficacy of a Dissolvable Strip in Providing Rapid Relief From Dentinal Hypersensitivity.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A proof of principle single-centre, randomized-controlled, examiner-blind, two treatment group study to investigate the efficacy of an experimental 15% w/w dissolvable strip in relieving dentine hypersensitivity (DH) after a single application and up to 4 hours after application compared to no treatment.

Detailed description

This was a single-centre, randomized-controlled, examiner-blind, two treatment group (test and no treatment), parallel design, stratified (by maximum baseline Schiff sensitivity score of the two selected test teeth) study, in healthy participants with at least two sensitive teeth that meet all the criteria at the screening and the baseline pre-treatment visit. Participants were screened for study suitability at screening visit (Visit 1). At Visit 2 (baseline; pre-treatment) 2 non-adjacent accessible teeth (incisors, canines, premolars) in different quadrants of the mouth and separated by at least 2 teeth (or equivalent edentulous space) were identified that demonstrated signs of sensitivity as measured by a qualifying tactile stimulus (Yeaple ≤ 20 gram \[g\]) and evaporative air assessment (Schiff sensitivity score ≥ 2) on the facial/cervical (ie, labial/buccal) tooth surface. Once the 2 test teeth were selected, the subjects were stratified (by maximum baseline Schiff sensitivity score of the 2 selected test teeth) and randomized to treatment or no treatment. DH was assessed at baseline (pre-treatment), and 10mins, 2 \& 4 hours post-treatment.

Conditions

Interventions

TypeNameDescription
DEVICEDissolvable polymer strip containing Novamin (calcium sodium phosphosilicate)Experimental dissolvable polymer strip containing Novamin (15% weight by weight\[w/w\] calcium sodium phosphosilicate).

Timeline

Start date
2016-11-21
Primary completion
2016-12-22
Completion
2016-12-22
First posted
2016-10-18
Last updated
2018-01-29
Results posted
2017-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02937623. Inclusion in this directory is not an endorsement.